Advaxis, Inc.
Advaxis Scientific Founder Published in Prestigious Peer-Reviewed Journal of Immunology
Published in Blood Weekly, May 28th, 2009
Dr. Yvonne Paterson (University of Pennsylvania), scientific founder of Advaxis, Inc. (OTCBB: ADXS) and members of her laboratory have a recently published work in the peer-reviewed Journal of Immunology on a new anti-angiogenic cancer vaccine (Seavey et al . J.I., 2009. 182:5537-46). This agent uses Advaxis proprietary technology to deliver the antigen VEGF-2 (aka fetal liver kinase-1) fused to a non-hemolytic form of the bacterial adjuvant Listeriolysin-O via a bioengineered strain of living Listeria monocytogenes.
As reported in the paper, “Lm-Listeriolysin-O-fetal liver kinase-1 was able to eradicate some established breast tumors, reduce micro-vascular density in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2009-05-28)
More Articles from Blood Weekly
- JAMA and Archives Journals
Policies on organ donation after cardiac death vary considerably among children's hospitals - University of Montreal
22-year study finds adults aren't active enough - Angiogenesis
Findings from T.T.F. Shih and co-authors broaden understanding of angiogenesis - Angiogenesis
Research on angiogenesis published by scientists at Celgene Corporation - Cancer
Findings from University of Texas provide new insights into cancer - Cancer
Retrospective Analysis Finds Treatment of Cancer Chemotherapy Patients With Epoetin Alfa Associated With Lower Drug Cost Than Darbepoetin Alfa - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
